Indomethacin for asymptomatic patent ductus arteriosus in preterm infants
about
Role of prophylactic surgical ligation of patent ductus arteriosus in extremely low birth weight infants: Systematic review and implications for clinical practicePredictors of bronchopulmonary dysplasiaPlatelet transfusions in infants with necrotizing enterocolitis do not lower mortality but may increase morbidity.The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review.Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration.Effects of intravenous indomethacin on reduction of symptomatic patent ductus arteriosus cases and decreasing the need for prolonged mechanical ventilation.Patent ductus arteriosus in premature neonates.Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?Current Status of Therapeutic Strategies for Patent Ductus Arteriosus in Very-Low-Birth-Weight Infants in Korea.The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasiaPatent ductus arteriosus: lack of evidence for common treatments.Conservative treatment for patent ductus arteriosus in the preterm.Nonsteroidal anti-inflammatory administration and patent ductus arteriosus ligation, a survey of practice preferences at US children's hospitals.Serial echocardiography in very preterm infants: a pilot randomized trialPatent ductus arteriosus in preterm infants: do we have the right answers?Preterm patent ductus arteriosus: should we treat it?Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.Potential and Limitations of Cochrane Reviews in Pediatric Cardiology: A Systematic Analysis.Neonatologist-performed point-of-care functional echocardiography in the neonatal intensive care unit.Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants.Comparative Effectiveness of Nonsteroidal Anti-inflammatory Drug Treatment vs No Treatment for Patent Ductus Arteriosus in Preterm Infants.Effects of Prophylactic Indomethacin on Vasopressor-Dependent Hypotension in Extremely Preterm Infants.Clinical considerations for the pharmacologic management of patent ductus arteriosus with cyclooxygenase inhibitors in premature infants.Treatment and Nontreatment of the Patent Ductus Arteriosus: Identifying Their Roles in Neonatal Morbidity.B-type natriuretic peptide may have a role in the management of patent ductus arteriosus.Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial)
P2860
Q24631088-294C6B9B-E79D-4F29-9734-9B69D4E981CEQ26829843-2A25B70D-B830-450E-85CB-47FDCD04426FQ33363972-D6413046-012B-44A1-93E3-6E294B1C775FQ34018364-0E5A42BF-A123-4481-B89C-2D617079BB96Q34517223-E91400F9-8593-4664-B2D9-B3B94A5D5324Q34925657-B288C1BE-DFEC-431B-9EDA-1D6E2EE0A33DQ35607990-3FD1A923-3BEB-4EDA-910A-D2908AA19D20Q35834962-70BD4B7E-490E-4A3E-B727-377D19AB5380Q36269441-D0FD8E77-D31E-4D5B-8B52-60F29CBECE1EQ36768333-ACF2466E-852C-4928-B482-3E59C1DE4111Q36977136-DF818527-BFCE-419E-A58C-4AC8E8A67788Q37174836-4F88530B-397B-4D19-A4D1-8A1415B84144Q37324451-8969E449-D598-4E3D-B860-CC7AB00871B2Q37401617-B308C79F-2BA9-496B-9031-E745A61B8088Q37451050-FDAB482B-0C1E-4A17-B70C-E742453BB0C8Q38042655-3BB1942F-B3FF-4053-8AFA-36846F556700Q38843760-059F1B67-E5C5-48FC-9D9D-0D1F8BE2FB35Q38940637-73D2C5D6-2D9E-40EA-BC84-580BCBC9D566Q39325597-EA677E2A-92DE-47F6-8D9A-67D3CB940CABQ40127221-4A62698D-58FE-436D-A7F9-573694C6CFE5Q40398107-F29B3947-6FE9-42EE-B328-4114CAB6BEB7Q40442960-38C6CC3B-34A8-4FD2-B71C-0395AD17DC20Q42534997-4912BBE2-BD47-4ACF-A11D-57B2B9079025Q46123190-E7EB77AE-1964-4690-9FD8-C3356A6BBF2CQ55284630-33A36BF8-64B7-4E54-8D10-E6825E8EB11DQ58800590-54AE4D66-A34C-44A5-A834-A11E72FF0E61
P2860
Indomethacin for asymptomatic patent ductus arteriosus in preterm infants
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Indomethacin for asymptomatic patent ductus arteriosus in preterm infants
@ast
Indomethacin for asymptomatic patent ductus arteriosus in preterm infants
@en
Indomethacin for asymptomatic patent ductus arteriosus in preterm infants
@en-gb
Indomethacin for asymptomatic patent ductus arteriosus in preterm infants
@nl
type
label
Indomethacin for asymptomatic patent ductus arteriosus in preterm infants
@ast
Indomethacin for asymptomatic patent ductus arteriosus in preterm infants
@en
Indomethacin for asymptomatic patent ductus arteriosus in preterm infants
@en-gb
Indomethacin for asymptomatic patent ductus arteriosus in preterm infants
@nl
prefLabel
Indomethacin for asymptomatic patent ductus arteriosus in preterm infants
@ast
Indomethacin for asymptomatic patent ductus arteriosus in preterm infants
@en
Indomethacin for asymptomatic patent ductus arteriosus in preterm infants
@en-gb
Indomethacin for asymptomatic patent ductus arteriosus in preterm infants
@nl
P2093
P2860
P1476
Indomethacin for asymptomatic patent ductus arteriosus in preterm infants
@en
P2093
Lucy Cooke
Paul G Woodgate
Peter A Steer
P2860
P356
10.1002/14651858.CD003745
P577
2003-01-20T00:00:00Z